Sysmex Astrego AB

📍 Uppsala, Sweden🗓 Founded 2017👥 63 employees💰 Last funded May 2022
Medical Equipment Manufacturing🌐 sysmex-astrego.se
Website LinkedIn
Sysmex Astrego is a rapidly growing in vitro diagnostic company based in Uppsala, Sweden. The company was founded as Astrego Diagnostics in March 2017 and was acquired by Sysmex Corporation, Japan, in May 2022 when the new entity Sysmex Astrego AB was formed. The company name comes from Antibiotic Susceptibility Testing – AST, and rego – being latin for guide, steer or manage. Our mission is to help in the global fight against antimicrobial resistance (AMR) and our products are designed to guide physicians in the selection of effective antibiotic treatments to improve patient outcomes and make antibiotic stewardship easy. Our team combines multidisciplinary scientific excellence with seasoned entrepreneurs and diagnostic industry management.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Early stage· 1
?
Member of the board
early stage
Mar 2017
Mid stage· 1
Ove Öhman
Ove Öhman
Retired but still a bit busy…
Board Member
mid stage
9 investments
May 2022
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Sysmex Astrego AB?
Sysmex Astrego AB has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Sysmex Astrego AB last raise funding?
The most recent investment in Sysmex Astrego AB recorded on gritt.io was in May 2022.
When was Sysmex Astrego AB founded?
Sysmex Astrego AB was founded in 2017.
What industry is Sysmex Astrego AB in?
Sysmex Astrego AB operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Sysmex Astrego AB based?
Sysmex Astrego AB is headquartered in Uppsala, Sweden.